GJ-103 is an active analog of GJ072 which is a read-through compound (RTC). Chemical-induced read through of premature stop codons might be exploited as a potential treatment strategy for genetic disorders caused by nonsense mutations.
[1] Liutao Du, et al. Mol Ther. 2013 Sep;21(9):1653-60.
















